肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2015 JBCS临床实践指南：乳腺癌的病理诊断

2016-02-25 日本乳腺癌学会 Breast Cancer. 2016 Feb 25.

乳腺癌病理诊断

2016年2月，日本乳腺癌学会(JBCS)发布了乳腺癌的病理诊断指南2015年版，在本版指南中新增了临床关于Ki67和细胞块的问题，其他所有问题都是基于当前最新文章进行的修订。 指南诊断乳腺癌的病理诊断共提出了16个问题，20个推荐意见。

中文标题：

2015 JBCS临床实践指南：乳腺癌的病理诊断

英文标题：

The Japanese Breast Cancer Society clinical practice guidelines for pathological diagnosis of breast cancer, 2015 edition

发布机构：

日本乳腺癌学会

发布日期：

2016-02-25

简要介绍：

2016年2月，日本乳腺癌学会(JBCS)发布了乳腺癌的病理诊断指南2015年版，在本版指南中新增了临床关于Ki67和细胞块的问题，其他所有问题都是基于当前最新文章进行的修订。指南诊断乳腺癌的病理诊断共提出了16个问题，20个推荐意见。


相关资料下载：
[AttachmentFileName(sort=100, fileName=2015 JBCS临床实践指南：乳腺癌的病理诊断)] GetToolGuiderByIdResponse(projectId=1, id=af77e1c00125204a, title=2015 JBCS临床实践指南：乳腺癌的病理诊断, enTitle=The Japanese Breast Cancer Society clinical practice guidelines for pathological diagnosis of breast cancer, 2015 edition, guiderFrom=Breast Cancer. 2016 Feb 25., authorId=null, author=, summary=2016年2月，日本乳腺癌学会(JBCS)发布了乳腺癌的病理诊断指南2015年版，在本版指南中新增了临床关于Ki67和细胞块的问题，其他所有问题都是基于当前最新文章进行的修订。 指南诊断乳腺癌的病理诊断共提出了16个问题，20个推荐意见。 , cover=, journalId=null, articlesId=null, associationId=1033, associationName=日本乳腺癌学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Feb 25 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年2月，日本乳腺癌学会(JBCS)发布了乳腺癌的病理诊断指南2015年版，在本版指南中新增了临床关于Ki67和细胞块的问题，其他所有问题都是基于当前最新文章进行的修订。指南诊断乳腺癌的病理诊断共提出了16个问题，20个推荐意见。<div><br></div><div> 拓展指南：<strong>与<font color="red">乳腺癌</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=af77e1c00125204a" title="2015 JBCS临床实践指南：乳腺癌的病理诊断" target="_blank">2015 JBCS临床实践指南：乳腺癌的病理诊断</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3c34a1c001250228" title="2016 NCCN临床实践指南：乳腺癌筛查和诊断（2016.V1）" target="_blank">2016 NCCN临床实践指南：乳腺癌筛查和诊断（2016.V1）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=259f21c00123881a" title="2013 原发性乳腺癌规范化诊疗指南（试行）" target="_blank">2013 原发性乳腺癌规范化诊疗指南（试行）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d202b1c00122e7d1" title="中国晚期乳腺癌临床诊疗专家共识2016" target="_blank">中国晚期乳腺癌临床诊疗专家共识2016</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=469791c0012162c0" title="2015 ESMO临床实践指南：原发性乳腺癌的诊断、治疗与随访" target="_blank">2015 ESMO临床实践指南：原发性乳腺癌的诊断、治疗与随访</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E4%B9%B3%E8%85%BA%E7%99%8C" target="_blank">有关乳腺癌更多指南</a></ul></div>, tagList=[TagDto(tagId=285, tagName=乳腺癌), TagDto(tagId=1098, tagName=病理诊断)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5159, appHits=104, showAppHits=0, pcHits=3294, showPcHits=2311, likes=174, shares=2, comments=5, approvalStatus=1, publishedTime=Mon Aug 08 13:56:33 CST 2016, publishedTimeString=2016-02-25, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Mon Aug 08 13:56:33 CST 2016, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 08:24:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2015 JBCS临床实践指南：乳腺癌的病理诊断)])
2015 JBCS临床实践指南：乳腺癌的病理诊断
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=105264, encodeId=c352105264b5, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:40:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99980, encodeId=78d299980be, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:04:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99978, encodeId=18bc999e83f, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99979, encodeId=39be999e969, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-27 zibozhouping

    先下手为强?，学习学习，参考相关知识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=105264, encodeId=c352105264b5, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:40:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99980, encodeId=78d299980be, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:04:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99978, encodeId=18bc999e83f, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99979, encodeId=39be999e969, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=105264, encodeId=c352105264b5, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:40:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99980, encodeId=78d299980be, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:04:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99978, encodeId=18bc999e83f, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99979, encodeId=39be999e969, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=105264, encodeId=c352105264b5, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:40:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99980, encodeId=78d299980be, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:04:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99978, encodeId=18bc999e83f, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99979, encodeId=39be999e969, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续关注

    0

相关指南

2016ACOG实践简报：乳腺良性疾病的诊断和管理

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2016-07-19

中国晚期乳腺癌临床诊疗专家共识2016

中华医学杂志(National Medical Journal of China) · 2016-07-04

2015 ESMO临床实践指南：原发性乳腺癌的诊断、治疗与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2015-09-01

2016 ASCO：乳腺癌生存护理指南

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2016-05-30

2016 人表皮生长因子受体2阳性乳腺癌临床诊疗专家共识

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2016-04-12

2015 乳腺癌的临床试验终点事件的时间定义指南

国外肿瘤科相关专家小组（统称） · 2015-02-27